Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Richards

Showing results (11-20 of 736) with videos related to

Pageof 74
Sort By:
European Journal of Heart Failure|February 16, 2021
Cardiac myosin-binding protein C as a candidate biomarker in heart failure: rational but not revolutionaryA Mark Richards
Cardiac Failure Review|August 9, 2017
Biomarkers in Acute Heart Failure - Cardiac And KidneyA Mark Richards
Heart (British Cardiac Society)|July 20, 2007
Variability of NT-proBNP levels in heart failure: implications for clinical applicationA Mark Richards
JACC. Heart Failure|August 15, 2016
The Relationship of Plasma NT-proBNP to Age and Outcomes in Heart FailureA Mark Richards
Clinical Chemistry|April 16, 2025
Cardiac Biomarkers in Pulmonary Embolism: Revealing or Redundant?A Mark Richards
European Journal of Heart Failure|May 16, 2023
Plasma markers to risk stratify for heart failure in atrial fibrillationA Mark Richards
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
C-type natriuretic peptide and cardiac fibrosisA Mark Richards
Nature Clinical Practice. Cardiovascular Medicine|October 3, 2007
Does NT-proBNP testing reduce costs and improve accuracy in the diagnosis of heart failure?A Mark Richards
Heart Failure Clinics|November 21, 2017
N-Terminal B-type Natriuretic Peptide in Heart FailureArthur Mark Richards
Journal of the American College of Cardiology|November 3, 2018
ST2 and Prognosis in Chronic Heart FailureA Mark Richards
Pageof 74

Showing results (11-20 of 736) with videos related to

Sort By:
Pageof 74
European Journal of Heart Failure|February 16, 2021
Cardiac myosin-binding protein C as a candidate biomarker in heart failure: rational but not revolutionaryA Mark Richards
Cardiac Failure Review|August 9, 2017
Biomarkers in Acute Heart Failure - Cardiac And KidneyA Mark Richards
Heart (British Cardiac Society)|July 20, 2007
Variability of NT-proBNP levels in heart failure: implications for clinical applicationA Mark Richards
JACC. Heart Failure|August 15, 2016
The Relationship of Plasma NT-proBNP to Age and Outcomes in Heart FailureA Mark Richards
Clinical Chemistry|April 16, 2025
Cardiac Biomarkers in Pulmonary Embolism: Revealing or Redundant?A Mark Richards
European Journal of Heart Failure|May 16, 2023
Plasma markers to risk stratify for heart failure in atrial fibrillationA Mark Richards
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
C-type natriuretic peptide and cardiac fibrosisA Mark Richards
Nature Clinical Practice. Cardiovascular Medicine|October 3, 2007
Does NT-proBNP testing reduce costs and improve accuracy in the diagnosis of heart failure?A Mark Richards
Heart Failure Clinics|November 21, 2017
N-Terminal B-type Natriuretic Peptide in Heart FailureArthur Mark Richards
Journal of the American College of Cardiology|November 3, 2018
ST2 and Prognosis in Chronic Heart FailureA Mark Richards
Pageof 74